The estimated Net Worth of Edward L Cahill is at least $59.1 Milion dollars as of 24 June 2021. Mr. Cahill owns over 5,000 units of Tandem Diabetes Care Inc stock worth over $1,105,767 and over the last 21 years he sold TNDM stock worth over $57,769,258. In addition, he makes $202,466 as Independent Director at Tandem Diabetes Care Inc.
Sign up
Mr. Cahill TNDM stock SEC Form 4 insiders trading
Edward has made over 10 trades of the Tandem Diabetes Care Inc stock since 2003, according to the Form 4 filled with the SEC. Most recently he sold 5,000 units of TNDM stock worth $300,150 on 24 June 2021.
The largest trade he's ever made was selling 2,181,577 units of Tandem Diabetes Care Inc stock on 17 December 2019 worth over $53,405,005. On average, Edward trades about 32,462 units every 91 days since 2003. As of 24 June 2021 he still owns at least 25,878 units of Tandem Diabetes Care Inc stock.
You can see the complete history of Mr. Cahill stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Edward Cahill biography
Edward L Cahill has served on our board of directors since May 2009. He has served as Managing Partner of HLM Venture Partners, a venture capital firm that invests primarily in emerging companies focused on healthcare information technology, healthcare services and medical technology, since May 2000. He served as a director of Animas Corporation, a developer of external insulin pumps, from March 2001 until its acquisition by Johnson & Johnson in February 2006. From June 1995 to May 2000, Mr. Cahill served as a founding partner of Cahill, Warnock Company (now Camden Partners), a Baltimore venture capital firm. Previously, Mr. Cahill was a Managing Director of Alex.Brown & Sons, an investment services brokerage, where he headed the firm’s healthcare group from January 1986 through March 1995. Mr. Cahill also serves as a director of Masimo Corporation (NASDAQ: MASI), a medical technology company. He is also a director of several private healthcare companies and serves as a trustee of Johns Hopkins Medicine, Johns Hopkins Health System and Mercy Health Services. Mr. Cahill holds an A.B. in American Civilization from Williams College and a Masters of Public and Private Management from Yale University.
What is the salary of Edward Cahill?
As the Independent Director of Tandem Diabetes Care Inc, the total compensation of Edward Cahill at Tandem Diabetes Care Inc is $202,466. There are 17 executives at Tandem Diabetes Care Inc getting paid more, with John Sheridan having the highest compensation of $10,560,900.
How old is Edward Cahill?
Edward Cahill is 61, he's been the Independent Director of Tandem Diabetes Care Inc since 2009. There are 4 older and 18 younger executives at Tandem Diabetes Care Inc. The oldest executive at Tandem Diabetes Care Inc is Dick Allen, 75, who is the Lead Independent Director.
What's Edward Cahill's mailing address?
Edward's mailing address filed with the SEC is C/O PHREESIA, 1521 CONCORD PIKE, SUITE 301 PMB 221, WILMINGTON, DE, 19803.
Insiders trading at Tandem Diabetes Care Inc
Over the last 11 years, insiders at Tandem Diabetes Care Inc have traded over $154,253,951 worth of Tandem Diabetes Care Inc stock and bought 4,118,443 units worth $11,618,906 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Douglas A Roeder a Nicole Vitullo. On average, Tandem Diabetes Care Inc executives and independent directors trade stock every 9 days with the average trade being worth of $885,878. The most recent stock trade was executed by Shannon Marie Hansen on 15 August 2024, trading 1,968 units of TNDM stock currently worth $84,093.
What does Tandem Diabetes Care Inc do?
tandem diabetes care, inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. the company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. tandem manufactures and sells the t:slim x2™ insulin pump, the only pump capable of remote feature updates using a personal computer, and the t:flex® insulin pump, the first pump designed for people with greater insulin requirements. tandem is based in san diego, california. safety information please note that this account is not intended to be used for product support or medical advice. if you are having a medical emergency, please dial 911. if you are having an issue with one of our products and need immediate assistance, please call our 24 hour customer support team at 877-801-6901 and press 1 twice. tandem insulin pumps are intended for the subcutan
What does Tandem Diabetes Care Inc's logo look like?
Complete history of Mr. Cahill stock trades at Masimo Corp, Tandem Diabetes Care Inc, Centene a Phreesia Inc
Tandem Diabetes Care Inc executives and stock owners
Tandem Diabetes Care Inc executives and other stock owners filed with the SEC include:
-
John Sheridan,
President, Chief Executive Officer, Director -
Kim Blickenstaff,
Chairman of the Board -
Brian Hansen,
Chief Commercial Officer, Executive Vice President -
Leigh Vosseller,
Chief Financial Officer, Executive Vice President, Treasurer -
David Berger,
Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary -
Susan Morrison,
Executive Vice President, Chief Administrative Officer -
Rebecca Robertson,
Independent Director -
John F. Sheridan,
Pres, CEO & Director -
David B. Berger Esq.,
Exec. VP & COO -
Elizabeth Anne Gasser,
Exec. VP & Chief Strategy Officer -
Brian B. Hansen,
Exec. VP & Chief Commercial Officer -
Leigh A. Vosseller,
Exec. VP, CFO & Treasurer -
David B. Berger,
Exec. VP, Chief Bus. Operations & Compliance Officer and Corp. Sec. -
Susan M. Morrison,
Exec. VP & Chief Admin. Officer -
Dick Allen,
Lead Independent Director -
Christopher Twomey,
Independent Director -
Douglas Roeder,
Independent Director -
Edward Cahill,
Independent Director -
Peyton Howell,
Independent Director -
Kathleen McGroddy-Goetz,
Independent Director -
Elizabeth Gasser,
Executive Vice President - Strategy and Corporate Development -
Shannon M. Hansen,
Sr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec. -
Manuel Jaime,
Sr. VP of Technology & Digital Health -
Tom Fox,
Sr. VP of HR & Organizational Devel. -
Ross Sylvia,
VP of Marketing -
Rick Carpenter,
Chief Technical Officer -
Jim Leal,
Sr. VP of Operations -
Richard P. Valencia,
Director -
Jesse I Treu,
Director -
Howard E Jr Greene,
Director -
Fred E Cohen,
Director -
Lonnie M Smith,
Director -
Henry Anhalt,
Director -
John Cajigas,
CHIEF FINANCIAL OFFICER -
Management Partners Viii, L...,
-
Venture Partners Ii, L.P.Hl...,
-
Group Holdings (Sbs) Adviso...,
-
Parters Vii L P Domain,
10% owner -
Nicole Vitullo,
10% owner -
Kathleen K Schoemaker,
10% owner -
Brian K Halak,
10% owner -
Robert Anacone,
EXECUTIVE VP AND CCO -
Brian H Dovey,
10% owner -
James C Blair,
10% owner -
Vii Associates Lp Dp,
10% owner -
Jean Claude Kyrillos,
EVP & Chief Operating Officer -
Rajwant Sodhi,
Director -
James Leal,
Chief Manufacturing Officer -
Shannon Marie Hansen,
EVP & Chief Legal Officer -
Myoungil Cha,
Director -
Joao Paulo Falcao Malagueira,
Director -
Mark David Novara,
EVP & CHIEF COMMERCIAL OFFICER -
Rick Carpenter,
Chief Technology Officer